This program will focus on coronary artery disease risk stratification and MI quantification, guidelines, health policy and appropriate use criteria improving clinical practice. Attending this one-day event will highlight the data that has been the clinical gold standard and the advances in medicine to advance care for this patient population. The program will recognize the contributions of Raymond J. Gibbons, M.D., a recognized cardiologist, educator and researcher in the Department of Cardiovascular Medicine.
Upon completion of this activity, participants should be able to:
- Identify the evolving need for risk stratification in the evaluation of suspected coronary artery disease
- Review the challenge of adequately powering randomized clinical trials in an era of declining cardiac event rates
- Describe the tension between scientific evidence review and clinical utility in the development of clinical practice guidelines
This program will connect Mayo Clinic faculty, alumni, providers and researchers, cardiologists and surgeons committed to improving the lives of patients with cardiac disease.